Eurofins Viracor Expands Cytokine Testing Portfolio
LENEXA, Kan., July 16, 2026 Eurofins Viracor has expanded its immunology testing portfolio with the launch of three new...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LENEXA, Kan., July 16, 2026 Eurofins Viracor has expanded its immunology testing portfolio with the launch of three new...
JERUSALEM, July 15, 2026 Alpha Tau Medical announced the successful treatment of the first patient in its ADMIRE clinical...
NEW HAVEN, Conn., July 6, 2026 Invivyd announced that the U.S. Food and Drug Administration (FDA) has issued a...
SAN FRANCISCO, May 28, 2026 Alife Health has achieved a major milestone in reproductive medicine with the U.S. Food...
SAN DIEGO, June 1, 2026 Ansun Biopharma has announced a significant clinical development milestone after an independent Data Monitoring...
LONDON, United Kingdom, May 20, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved...
